Re-lieved Lidocaine Patch
FDA Label NDC 71662-000

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Transfer Technology for the product Re-lieved Lidocaine Patch (NDC 71662-000). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, use, warnings, do not use, otc - when using, pregnancy, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

Lidocaine 4%

Purpose

Topical Analgesic

Use

For the temporary relief of pain

Warnings

For external use only

Do Not Use

If you are allergic to any ingredient in Re-Lieved Lidocaine Patch, on open wounds or damaged irritated skin.  

Ask your doctor or pharmacist before use if you are using blood thining medication, steroids, or non-steroidal anti-inflammatory drugs (NSAIDS)

Otc - When Using

When using this product

  • do not use other topical products
  • avoid contact with eyes or mucous membranes
  • keep away from excessive heat

Pregnancy

If pregnant or breastfeeding ask a physican before use.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If put in mouth, get medical help or contact a poison control center right away.

Other Safety Information

Other information

  • Store at room temperature
  • Do not exceed 100 o Fahrenheit 38 o Celsius
  • For easier removal of patch apply rubbing alcohol or baby oil to adhesive edge

Inactive Ingredient

Inactive ingredients: Acrylic adhesive, polyethylene foam

Re-Lieved Lidocaine 4% Patch

Re-lieved Lidocaine Box (Relievedbagdesign8.17front)

Re-lieved Lidocaine Box (Relievedbagdesign8.17front)

Drug Facts Panel

Drug Facts Panel (Relievedbagdesign8.17back)

Drug Facts Panel (Relievedbagdesign8.17back)

* Please review the disclaimer below.